TY  - GEN
N2  - This book provides a comprehensive review of novel adaptive trial designs for targeted therapies and immunotherapies. This book covers a wide range of novel statistical designs for various clinical settings, including early phase dose-escalation study, proof-of-concept trials, and confirmatory studies with registrational. The book includes real-life examples and software to facilitate practitioners to learn and use the designs in practice.
DO  - 10.1007/978-981-19-8176-0
DO  - doi
AB  - This book provides a comprehensive review of novel adaptive trial designs for targeted therapies and immunotherapies. This book covers a wide range of novel statistical designs for various clinical settings, including early phase dose-escalation study, proof-of-concept trials, and confirmatory studies with registrational. The book includes real-life examples and software to facilitate practitioners to learn and use the designs in practice.
T1  - Bayesian adaptive design for immunotherapy and targeted therapy /
AU  - Pan, Haitao,
AU  - Yuan, Ying,
CN  - RM276
ID  - 1463521
KW  - Immunotherapy
KW  - Drug targeting
KW  - Clinical trials
KW  - Bayesian statistical decision theory.
SN  - 9789811981760
SN  - 9811981760
TI  - Bayesian adaptive design for immunotherapy and targeted therapy /
LK  - https://univsouthin.idm.oclc.org/login?url=https://link.springer.com/10.1007/978-981-19-8176-0
UR  - https://univsouthin.idm.oclc.org/login?url=https://link.springer.com/10.1007/978-981-19-8176-0
ER  -